Parallel Advisors, LLC Royalty Pharma PLC Transaction History
Parallel Advisors, LLC
- $4.31 Billion
- Q1 2025
A detailed history of Parallel Advisors, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Parallel Advisors, LLC holds 4,423 shares of RPRX stock, worth $137,687. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,423
Previous 3,625
22.01%
Holding current value
$137,687
Previous $92,000
48.91%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding RPRX
# of Institutions
438Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.23 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.16 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$717 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$528 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$440 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.6B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...